Krsnaa Diagnostics — 360° view

Krsnaa Diagnostics, a company in the Healthcare Service Provider industry, reported revenue of ₹240 crore and net profit of ₹25 crore for the September 2026 quarter.

Krsnaa Diagnostics (NSE: KRSNAA) closed at ₹519.05 on 20 Nov 2026, down 36.5% over the past year. Its market capitalisation is ₹1,684 crore and it trades at 16.7 times earnings.

Share price
₹519.05 (20 Nov 2026)
Market cap
₹1,684 Cr (20 Nov 2026)
P/E
16.67 (20 Nov 2026)
Revenue
₹240 Cr (September 2026 quarter)
Net profit
₹25 Cr (September 2026 quarter)
ROCE
12.7% (FY26)
ROE
10.9% (FY26)
Book value
₹324 (FY26)
Dividend yield
0.39% (last 12 months to 20 Nov 2026)
52-week high / low
₹835.40 / ₹463.10 (20 Nov 2026)
1-year return
-36.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: KRSNAA

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.